Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Castro

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Pediatrics|March 4, 2009
Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?Mark N Lobato, John A Jereb, Kenneth G Castro
Emerging Infectious Diseases|November 20, 2020
Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and ControlPhilip C Hopewell, Lee B Reichman, Kenneth G Castro
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2003
Tuberculosis contact investigationsMary R Reichler, Sue Etkind, Zachary Taylor, et al.
Plos One|October 14, 2020
Assessment of early mitigation measures against COVID-19 in Puerto Rico: March 15-May 15, 2020Miguel Valencia, José E Becerra, Juan C Reyes, et al.
Expert Review of Molecular Diagnostics|November 7, 2014
Evaluation of the Cepheid Xpert MTB/RIF assayThomas M Shinnick, Angela M Starks, Heather L Alexander, et al.
Chest|March 12, 2003
Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infectionKenneth G Castro, John A Jereb, Venkatarama Rao Koppaka, et al.
Annals of Internal Medicine|January 9, 2018
Seven Deadly Sins Resulting From the Centers for Disease Control and Prevention's Seven Forbidden WordsKenneth G Castro, Dabney P Evans, Carlos Del Rio, et al.
Plos Medicine|November 9, 2007
Randomized trials to optimize treatment of multidrug-resistant tuberculosisCarole D Mitnick, Kenneth G Castro, Mark Harrington, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2008
No man is an island: reducing diagnostic delays in undocumented foreign-born persons is needed to decrease the risk of tuberculosis transmissionKevin P Cain, William R Mac Kenzie, Kenneth G Castro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infectionKashef Ijaz, Peter D McElroy, John Jereb, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Pediatrics|March 4, 2009
Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?Mark N Lobato, John A Jereb, Kenneth G Castro
Emerging Infectious Diseases|November 20, 2020
Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and ControlPhilip C Hopewell, Lee B Reichman, Kenneth G Castro
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 18, 2003
Tuberculosis contact investigationsMary R Reichler, Sue Etkind, Zachary Taylor, et al.
Plos One|October 14, 2020
Assessment of early mitigation measures against COVID-19 in Puerto Rico: March 15-May 15, 2020Miguel Valencia, José E Becerra, Juan C Reyes, et al.
Expert Review of Molecular Diagnostics|November 7, 2014
Evaluation of the Cepheid Xpert MTB/RIF assayThomas M Shinnick, Angela M Starks, Heather L Alexander, et al.
Chest|March 12, 2003
Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infectionKenneth G Castro, John A Jereb, Venkatarama Rao Koppaka, et al.
Annals of Internal Medicine|January 9, 2018
Seven Deadly Sins Resulting From the Centers for Disease Control and Prevention's Seven Forbidden WordsKenneth G Castro, Dabney P Evans, Carlos Del Rio, et al.
Plos Medicine|November 9, 2007
Randomized trials to optimize treatment of multidrug-resistant tuberculosisCarole D Mitnick, Kenneth G Castro, Mark Harrington, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2008
No man is an island: reducing diagnostic delays in undocumented foreign-born persons is needed to decrease the risk of tuberculosis transmissionKevin P Cain, William R Mac Kenzie, Kenneth G Castro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infectionKashef Ijaz, Peter D McElroy, John Jereb, et al.
Pageof 7